Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older
Authors:
- 5 September 2006
- journal article
- clinical trial
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 21 (9) , 898-901
Abstract
Introduction: Treatment studies of depression in the very oldest patients are infrequent. For these reasons, this study of mirtazapine orally disintegrating tablets was carried out in nursing home residents ≥85 years old with physician‐diagnosed depression. The naturalistic conditions of the study allowed us to include patients with cognitive impairment, concomitant medications and comorbid illness.Methods: This was a subgroup analysis of nursing home residents ≥85 years old who took part in a larger 12‐week open‐label trial. Patients were eligible if they had physician‐diagnosed depression, and a Mini‐Mental State Exam score ≥10. The physician or nurse coordinator obtained data from healthcare professionals in daily contact with the patient to complete the Clinical Global Impression (CGI) scale, a modified 16‐item Hamilton Depression Scale (HAM‐D), and the Cornell Scale for Depression in Dementia (CSDD). Treatment‐emergent adverse events were recorded.Results: Of the 50 patients enrolled at 23 sites, 72% completed the 12‐week trial. The mean age of the participants was 89.3 years. The mean HAM‐D score declined from 16.9 at baseline to 7.3 at endpoint (ITT, LOCF analysis) For the CSDD, the mean score declined from 15.1 to 7.1. The percentage of responders on the CGI‐Improvement (CGI‐I) scale increased at each assessment reaching 55% at endpoint. Only 10% of the patients discontinued treatment because of adverse events. There was a mean increase in weight of 1.32 lbs (0.6 kg) at day 84.Conclusion: Although lacking a placebo control, this naturalistic study suggests that mirtazapine orally disintegrating tablets were effective and well tolerated in this sample of depressed nursing home residents ≥85 years of age. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 17 references indexed in Scilit:
- Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing homeCurrent Medical Research and Opinion, 2003
- A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home SettingJournal of the American Geriatrics Society, 2001
- MirtazapineDrugs, 1999
- Meta‐analysis of randomized, double‐blind, dacebo‐controlled, efficacy and safety studies of mirtazapine versus amitripcyline in major depressionActa Psychiatrica Scandinavica, 1997
- A Multifactorial Intervention to Reduce the Risk of Falling among Elderly People Living in the CommunityNew England Journal of Medicine, 1994
- Falls in the Nursing HomeAnnals of Internal Medicine, 1994
- The α2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivoEuropean Journal of Pharmacology, 1994
- Cornell scale for depression in dementiaBiological Psychiatry, 1988
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960